On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...